Enoticumab

Enoticumab (REGN421, INN) is a human monoclonal antibody that binds to DLL4. It acts as an immunomodulator.^{[1][2][3][4][5]}

Enoticumab

Monoclonal antibody
Type	Whole antibody
Source	Human
Target	DLL4
Clinical data
Other names	REGN421
ATC code	none
Identifiers
CAS Number	1192578-27-0
ChemSpider	none
UNII	B59DCD0F7D
KEGG	D10460 Y